Skip to main content
. Author manuscript; available in PMC: 2016 Feb 15.
Published in final edited form as: Am J Cardiol. 2014 Nov 29;115(4):515–522. doi: 10.1016/j.amjcard.2014.11.037

Table 2.

Factors associated with false negative and false positive compared to true negative and true positive electrocardiographic left ventricular hypertrophy (ECG-LVH) in a bivariate logistic regression

False negative False positive

Variable Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value

Age (year) 1.01 (1.00, 1.02) 0.054 0.98 (0.96, 1.00) 0.080
Sex (men vs. women) 0.71 (0.58, 0.88) 0.002 1.03(0.65, 1.64) 0.896
Race/Ethnicity <0.001 0.001
  White (Reference) (Reference)
  Chinese-Americans 0.43 (0.26, 0.71) 0.001 1.22 (0.48, 3.10) 0.679
  Hispanics 1.67 (1.28, 2.18) <0.001 0.28 (0.12, 0.67) 0.004
  Blacks 1.79 (1.39, 2.32) <0.001 0.34 (0.16, 0.73) 0.006
Body mass index (kg/m2) 1.07 (1.05, 1.09) <0.001 0.93 (0.89, 0.98) 0.006
Income <0.001 0.085
  <$20K) (Reference) (Reference)
  >$20k<$50K 1.16 (0.88, 1.52) 0.284 0.98 (0.56, 1.69) 0.928
  >$50K 0.70 (0.53, 0.94) 0.017 1.87(0.99, 3.54) 0.055
Education 0.265 0.407
  High School (Reference) (Reference)
  College 0.85 (0.65, 1.13) 0.263 1.40 (0.81, 2.43) 0.226
  >College 0.75 (0.53, 1.06) 0.105 1.50 (0.75, 3.00) 0.257
Hypertension 3.47 (2.78, 4.33) <0.001 0.33 (0.19, 0.58) 0.001
Systolic blood pressure (mmHg) 1.03 (1.03, 1.04) <0.001 0.97 (0.96, 0.98) <.001
Diastolic blood pressure ( mmHg) 1.04 (1.03, 1.05) <0.001 0.95 (0.93, 0.97) <.001
Blood pressure lowering drugs 2.21 (1.79, 2.72) <0.001 0.74 (0.46, 1.18) 0.207
Total cholesterol ( mg/dL) 1.00 (1.00, 1.00) 0.841 1.00 (0.99, 1.01) 0.846
HDL-cholesterol (mg/dL) 1.00 (0.99, 1.01) 0.759 1.00 (0.98, 1.02) 0.925
Statin use 0.98 (0.73, 1.33) 0.911 0.93 (0.48, 1.81) 0.838
Diabetes Mellitus 1.85 (1.40, 2.45) <0.001 0.41 (0.23, 0.76) 0.004
Family history of CVD 1.17 (0.94, 1.46) 0.147 0.91 (0.56, 1.47) 0.690
Smoking status <0.001 0.041
  Never (Reference) (Reference)
  Current 2.07 (1.56, 2.75) <0.001 0.44 (0.22, 0.87) 0.018
  Past 1.12 (0.88, 1.42) 0.356 1.07 (0.62, 1.83) 0.810
LV ejection fraction (%) 0.96 (0.94, 0.97) <0.001 1.04 (1.01, 1.07) 0.002
MRI-LV mass (gm) 1.16 (1.15, 1.18) <0.001 0.86 (0.83, 0.89) <.001
QRS duration (ms) 1.04 (1.03, 1.05) <0.001 1.00 (0.98, 1.02) 0.911
Abnormal QRS axis 1.16 (0.72, 1.86) 0.550 1.01 (0.41, 2.46) 0.982
Any ST/T abnormalities 2.70 (2.11, 3.47) <0.001 0.34 (0.21, 0.55 <.001
Minor ST/T abnormalities 2.99 (2.32, 3.85) <0.001 0.37 (0.23, 0.61) <.001
Major ST/T abnormalities 1.75 (1.06, 2.87) 0.028 0.27 (0.14, 0.49) <.001
Any major ECG abnormalities 1.79 (1.27, 2.52) 0.001 0.30 (0.18, 0.52) <.001

ECG-LVH status was defined using left ventricular hypertrophy by magnetic resonance imaging (MRI-LVH) as the gold standard

HDL= High density lipoprotein; CVD= Cardiovascular disease; LV= Left ventricle; MRI= Magnetic resonance imaging